| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |